Neuroacanthocytosis
INTRODUCTION The term “acanthocytosis” is derived from Greek to describe “thorny” red blood cells. The actual process resulting in the formation of acanthocytes is not known. Echinocytes, which are found…
Sleep and Fatigue in Parkinson’s Disease
Sleep disorders and fatigue are clinically relevant problems that are increasingly recognized as an integral part of Parkinson’s disease (PD). The interest in these topics is attested by the large…
Surgery for Parkinson’s Disease
INTRODUCTION Despite the recent remarkable advances in science that have delivered new pharmaceutical and other therapeutic strategies for Parkinson’s disease (PD) treatment, there remains a select group of patients who…
Paroxysmal Dyskinesias
Paroxysmal movement disorders are defined as abnormal involuntary movements that are intermittent or episodic in nature, with sudden onset and variable duration, and with no change in consciousness (1). The…
Restless Legs Syndrome and Akathisia
CLINICAL RESTLESS LEGS SYNDROME Restless legs syndrome (RLS) is clinically defined by the presence of four criteria: (1) an urge to move the limbs with or without sensations, (2) worsening…
Extrapyramidal Syndromes in Frontotemporal Dementia
Related posts: Neurologic Aspects of Wilson’s Disease: Clinical Manifestations and Treatment Considerations Catatonia Treatment of Dystonia Cell-Based Therapy for Parkinson’s Disease Myoclonus and Exaggerated Startle Syndrome Botulinum Toxin in Movement…
Experimental Therapeutics of Parkinson’s Disease
INTRODUCTION Parkinson’s disease (PD) remains the only neurodegenerative disorder for which there are highly efficacious symptomatic therapies, most importantly dopamine (DA) replacement strategies, which in most patients provide satisfactory motor…
Progressive Supranuclear Palsy
INTRODUCTION In 1963, J. Clifford Richardson (1) described an unusual syndrome of supranuclear gaze palsy, and progressive axial rigidity, pseudobulbar palsy, and mild dementia. Together with John Steele and Jerzy…
Movement Disorders in Systemic Disease
INTRODUCTION Movement disorders commonly occur in association with systemic diseases, and they may occasionally be the presenting feature of a systemic disease (1,2). It is therefore imperative to carefully consider…
Nonpharmacologic Multidisciplinary Approach to the Treatment of Parkinson’s Disease
Related posts: Neurologic Aspects of Wilson’s Disease: Clinical Manifestations and Treatment Considerations Catatonia Treatment of Dystonia Cell-Based Therapy for Parkinson’s Disease Myoclonus and Exaggerated Startle Syndrome Botulinum Toxin in Movement…
